According to Matinas BioPharma's latest financial reports the company's current EPS (TTM) is -$0.11. In 2022 the company made an earnings per share (EPS) of -$0.11 a decrease over its 2021 EPS that were of -$0.11.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.11 | -0% |
2022 | -$0.11 | -0% |
2021 | -$0.11 | -8.33% |
2020 | -$0.12 | -14.29% |
2019 | -$0.14 | -6.67% |
2018 | -$0.15 | -59.46% |
2017 | -$0.37 | 76.19% |
2016 | -$0.21 | 10.53% |
2015 | -$0.19 | -41.11% |
2014 | -$0.32 | 178.06% |
2013 | -$0.12 |